Hemophagocytic Lymphohistiocytosis Associated with the Use of Lamotrigine
Neurol 92:e2401-e2405, Kim, T.,et al, 2019
Dupuytren, Ledderhose, and Peyronie Diseases after Primidone Use for Essential Tremor
Neurologist 24:150-151, Felipe, L.,et al, 2019
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Serotonin Syndrome
BMJ 348:g1626, Buckley, N.A.,et al, 2014
Clinical Features of Dopamine Agonist Withdrawal Syndrome in a Movement Disorders Clinic
JNNP 84:130-135, Pondal, M.,et al, 2013
Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012
Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod
Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1134-1143, McCormack,M.,et al, 2011
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1126-1133, Chen,P.,et al, 2011
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
NEJM 365:285-287, Egan, A.,et al, 2011
Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011
Lamotrigine: An Unusual Etiology for Aseptic Meningitis
Neurologist 16:35-36, Lam,G.,et al, 2010
Polytherapy Increases the Risk of Infertility in Women With Epilepsy
Neurol 75:1351-1355, 1316, Sukumaran,S.C.,et al, 2010
Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010
Intrauterine Exposure to Carbamazepine and Specific Congenital Malformations: Systematic Review and Case-Control Study
BMJ 341:c6581, 1229, Jentik,J.,et al, 2010
Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008
Generic Substitution in the Treatment of Epilepsy: Case Evidence of Breakthrough Seizures
Neurol 71:525-530, Berg,M.J.,et al., 2008
Cerebellar Hemorrhage Provoked by Combined Use of Nattokinase and Aspirin in a Patient with Cerebral Microbleeds
Inter Med 47:467-469, Chang, Y.Y.,et al, 2008
Tiagabine-Induced Nonconvulsive Status Epilepticus in an Adolescent Without Epilepsy
Neurol 67:1514-1515, Jette,N.,et al, 2006
Reversible Anorgasmia With Topiramate Therapy for Migraine
Neurol 65:1333-1334, Newman,L.C.,et al, 2005
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
NEJM 350:896-903,860, Mutsch,M.,et al, 2004
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004
Agitation by Sedation
Lancet 361:308, Tuohy,K.A.,et al, 2003
Zonisamide-Induced Restless Legs Syndrome
Neurol 60:147, Chen,J.T.,et al, 2003
Severe Intoxication After Phenytoin Infusion: A Preventable Pharmacogenetic Adverse Reaction
Neurol 60:1395-1396, Citerio,G.,et al, 2003
Intrathecal Baclofen for Stiff-Person Syndrome: Life-Threatening Intermittent Catheter Leakage
Neurol 60:1976-1978, Bardutzky,J.,et al, 2003
Stroke Associated with Sympathomimetics Contained in Over-the Counter Cough and Cold Drugs
Stroke 34:1667-1673, Cantu,C.,et al, 2003
Sensorineural Hearing Loss: A Reversible Effect of Vigabatrin
Neurol 61:1020-1021, Papdeas,E.,et al, 2003
Chronic Diarrhea Associated with Vagal Nerve Stimulation
Neurol 58:330, Sanossian,N. &Haut,S., 2002
Vocal Cord Adduction During Vagus Nerve Stimulation for Treatment of Epilepsy
Neurol 54:1388-1389, Zumsteg,D.,et al, 2000
Epilepsy, Broken Bones, and Fatty Stools
Lancet 355:1882, Drenth,J.P.H.,et al, 2000
Evaluation of Refractory epilepsy Treated with Vagus Nerve Stimulation for Up to 5 Years
Neurol 52:1265-1267,1117, Ben-Menachem,E.,et al, 1999
Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy
Neurol 53:1731-1735, Morris,G.L.,et al, 1999
Herbal Remedies: Adverse Effects and Drug Interactions
Am Fam Physician 59:1239-1244, Cupp, M.J.,et al, 1999
Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998
Incidence and Clinical Consequence of the Purple Glove Syndrome in Patients Receiving Intravenous Phenytoin
Neurol 51:1034-1039,942, O'Brien,T.J.,et al, 1998
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997
Intractable Partial Epilepsy Following Low-Dose Scalp Irradiation in Infnacy
Ann Neurol 38:951-954, Reutens,D.C.,et al, 1995
Anticonvulsant Hypersensitivity Syndrome
Arch Int Med 155:2285-2290, Vittorio,C.C.&Muglia,J.J., 1995
Prolonged Paralysis after Treatment with Neuromuscular Junction Blocking Agents
Crit Care Med 19:1125-1131, Gooch,J.L.,et al, 1991
Risks Associated with Giving Benzodiazepines to Patients with Acute Neurological Injuries
BMJ 300:1189-1190, Eldridge,P.R.&Punt,J.A.G., 1990
Delirium in the Elderly Patient
NEJM 320:578-582, Lipowski,Z.J., 1989
Pseudostatus Epilepticus
Quart J Med 71:507-519, Howell,S.J.L.,et al, 1989
Disorders of Neuromuscular Transmission Caused by Drugs
NEJM 301:409-413, Argov,Z.,et al, 1979
Drug-Induced Neurologic Disorders in Childhood
Current Problems in Pediatrics 1:1, Schwartz,J., 1971